- Release of [OncoKB™ SOP v5.2](https://www.oncokb.org/sop)
- OncoTree updated from version 2019_12_01 to version [oncotree_candidate_release](https://oncotree.mskcc.org/?version=oncotree_candidate_release&field=NAME), which incorporates changes to the CNS branch of OncoTree
- Update to CDKN2A to include two distinct gene pages, for the [p16](https://www.oncokb.org/gene/CDKN2A) and [p14](<https://oncokb.org/gene/CDKN2A%20(p14)>) isoforms
- Transcripts have been updated for the following genes: [ATXN7](https://www.oncokb.org/gene/ATXN7), [CCNQ](https://www.oncokb.org/gene/CCNQ), [CRLF2](https://www.oncokb.org/gene/CRLF2), [GAB1](https://www.oncokb.org/gene/GAB1), [KBTBD4](https://www.oncokb.org/gene/KBTBD4), [MUTYH](https://www.oncokb.org/gene/MUTYH), [NADK](https://www.oncokb.org/gene/NADK), [PAX8](https://www.oncokb.org/gene/PAX8), [PGBD8](https://www.oncokb.org/gene/PGBD8), [RBM10](https://www.oncokb.org/gene/RBM10)

<details>
<summary>View details for updated transcripts</summary>

| Gene                                         | Old Transcript(s)               | Updated Transcript(s)                                 |
| :------------------------------------------- | :------------------------------ | :---------------------------------------------------- |
| [ATXN7](https://www.oncokb.org/gene/ATXN7)   | ENST00000295900 (GRCh37/GRCh38) | ENST00000398590.3 (GRCh37) ENST00000522345.2 (GRCh38) |
| [CCNQ](https://www.oncokb.org/gene/CCNQ)     | ENST00000576892 (GRCh37/GRCh38) | ENST00000406277.2 (GRCh37) ENST00000576892.8 (GRCh38) |
| [CRLF2](https://www.oncokb.org/gene/CRLF2)   | ENST00000381566 (GRCh37/GRCh38) | ENST00000400841.2 (GRCh37) ENST00000400841.8 (GRCh38) |
| [GAB1](https://www.oncokb.org/gene/GAB1)     | ENST00000262994 (GRCh37/GRCh38) | ENST00000262995.4 (GRCh37) ENST00000262995.9 (GRCh38) |
| [KBTBD4](https://www.oncokb.org/gene/KBTBD4) | ENST00000395288 (GRCh37/GRCh38) | ENST00000430070.2 (GRCh37) ENST00000430070.7 (GRCh38) |
| [MUTYH](https://www.oncokb.org/gene/MUTYH)   | ENST00000372115 (GRCh37/GRCh38) | ENST00000450313.1 (GRCh37) ENST00000710952.2 (GRCh38) |
| [NADK](https://www.oncokb.org/gene/NADK)     | ENST00000341426 (GRCh37/GRCh38) | ENST00000378625.1 (GRCh37) ENST00000378625.5 (GRCh38) |
| [PAX8](https://www.oncokb.org/gene/PAX8)     | ENST00000263334 (GRCh37/GRCh38) | ENST00000429538.3 (GRCh37) ENST00000429538.8 (GRCh38) |
| [PGBD8](https://www.oncokb.org/gene/PGBD8)   | ENST00000525115 (GRCh37/GRCh38) | ENST00000391860.1 (GRCh37) ENST00000391860.7 (GRCh38) |
| [RBM10](https://www.oncokb.org/gene/RBM10)   | ENST00000329236 (GRCh37/GRCh38) | ENST00000377604.3 (GRCh37) ENST00000377604.8 (GRCh38) |

</details>
<br></br>

**Updated Therapeutic Implications**

- New alteration(s) with a tumor type-specific level of evidence

| Level | Gene  | Mutation | Cancer Type                            | Drug(s) Added to OncoKB™ | Evidence                                                                                                                                                                                                                        |
| :---- | :---- | :------- | :------------------------------------- | :----------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| 1     | H3-3A | K28M     | Diffuse Midline Glioma, H3 K27-Altered | Dordaviprone (Level 1\)  | [FDA approval of dordaviprone](https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma); PMID: [38335473](https://pubmed.ncbi.nlm.nih.gov/38335473/) |
| 1     | H3C2  | K28M     | Diffuse Midline Glioma, H3 K27-Altered | Dordaviprone (Level 1\)  | [FDA approval of dordaviprone](https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma); PMID: [38335473](https://pubmed.ncbi.nlm.nih.gov/38335473/) |
| 1     | H3C3  | K28M     | Diffuse Midline Glioma, H3 K27-Altered | Dordaviprone (Level 1\)  | [FDA approval of dordaviprone](https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-dordaviprone-diffuse-midline-glioma); PMID: [38335473](https://pubmed.ncbi.nlm.nih.gov/38335473/) |
